{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:23:50Z","timestamp":1761708230758},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,7,17]],"date-time":"2008-07-17T00:00:00Z","timestamp":1216252800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urol Res"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1007\/s00240-008-0146-4","type":"journal-article","created":{"date-parts":[[2008,7,16]],"date-time":"2008-07-16T14:40:56Z","timestamp":1216219256000},"page":"233-239","source":"Crossref","is-referenced-by-count":8,"title":["Intestinal hyperabsorption of calcium and low bone turnover in hypercalciuric postmenopausal osteoporosis"],"prefix":"10.1007","volume":"36","author":[{"given":"Clarita V.","family":"Odvina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Poindexter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy D.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph E.","family":"Zerwekh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles Y. C.","family":"Pak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,7,17]]},"reference":[{"key":"146_CR1","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/jbmr.5650071205","volume":"7","author":"F Pietschmann","year":"1992","unstructured":"Pietschmann F, Breslau NA, Pak CYC (1992) Reduced vertebral bone density in hypercalciuric nephrolithiasis. J Bone Miner Res 7:1383\u20131388","journal-title":"J Bone Miner Res"},{"key":"146_CR2","first-page":"260","volume":"16","author":"R Caudarella","year":"2003","unstructured":"Caudarella R, Vescini F, Buffa A, Sinicropi G, Rizzoli E, La Manna G et al (2003) Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors. J Nephrol 16:260\u2013266","journal-title":"J Nephrol"},{"key":"146_CR3","first-page":"94","volume":"50","author":"S Giannini","year":"1998","unstructured":"Giannini S, Nobile M, Sartori L, Cal\u00f2 L, Tasca A, Dalle Carbonare L et al (1998) Bone density and skeletal metabolism are altered in idiopathic hypercalciuria. Clin Nephrol 50:94\u2013100","journal-title":"Clin Nephrol"},{"key":"146_CR4","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/sj.ki.5002181","volume":"71","author":"HJ Heller","year":"2007","unstructured":"Heller HJ, Zerwekh JE, Gottschalk FA, Pak CYC (2007) Increased bone resorption and reduced bone formation in moderate-severe absorptive hypercalciuria: bone histomorphometric analysis and alendronate challenge. Kidney Int 71:808\u2013815. doi: 10.1038\/sj.ki.5002181","journal-title":"Kidney Int"},{"key":"146_CR5","first-page":"175","volume":"42","author":"IP Heilberg","year":"1994","unstructured":"Heilberg IP, Martini LA, Szejnfeld VL, Carvalho AB, Draibe SA, Ajzen H et al (1994) Bone disease in calcium stone forming patients. Clin Nephrol 42:175\u2013182","journal-title":"Clin Nephrol"},{"key":"146_CR6","first-page":"393","volume":"15","author":"IP Heiberg","year":"2006","unstructured":"Heiberg IP, Weisinger JR (2006) Bone disease in idiopathic hypercalciuria. Curr Opin Nephrol Hypertens 15:393\u2013402","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"146_CR7","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1210\/jcem-50-4-654","volume":"50","author":"HH Malluce","year":"1980","unstructured":"Malluce HH, Tschoepe W, Ritz E, Meyer-Sabellek W, Massry SG (1980) Abnormal histology in idiopathic hypercalciuria. J Clin Endocrinol Metab 50:654\u2013658","journal-title":"J Clin Endocrinol Metab"},{"key":"146_CR8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1699-0463.1989.tb00793.x","volume":"97","author":"T Steiniche","year":"1988","unstructured":"Steiniche T, Moskilde L, Christensen MS, Melsen F (1988) A histomorphometric determination of iliac bone remodeling in patients with recurrent renal stone formation and idiopathic hypercalciuria. APMIS 97:309\u2013316","journal-title":"APMIS"},{"key":"146_CR9","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/ki.1996.34","volume":"49","author":"JR Weisinger","year":"1996","unstructured":"Weisinger JR, Alonzo E, Bellorin-Font F, Blasini AM, Rodriguez MA, Paz-Marinez V et al (1996) Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria. Kidney Int 49:244\u2013250. doi: 10.1038\/ki.1996.34","journal-title":"Kidney Int"},{"key":"146_CR10","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/BF01623819","volume":"2","author":"JE Zerwekh","year":"1992","unstructured":"Zerwekh JE, Sakhee K, Breslau NA, Gottschalk F, Pak CYC (1992) Impaired bone formation in male idiopathic osteoporosis: further reduction in the presence of concomitant hypercalciuria. Osteoporos Int 2:128\u2013134. doi: 10.1007\/BF01623819","journal-title":"Osteoporos Int"},{"key":"146_CR11","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1210\/jc.2004-2042","volume":"90","author":"MA Donovan","year":"2005","unstructured":"Donovan MA, Dempster D, Zhou H, McMahon DJ, Fleischer J, Shane E (2005) Low bone formation in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab 90:3331\u20133336. doi: 10.1210\/jc.2004-2042","journal-title":"J Clin Endocrinol Metab"},{"key":"146_CR12","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1210\/jc.2002-021660","volume":"88","author":"US Barzel","year":"2003","unstructured":"Barzel US (2003) Recommended testing in patients with low bone density. J Clin Endocrinol Metab 88:1404\u20131405. doi: 10.1210\/jc.2002-021660","journal-title":"J Clin Endocrinol Metab"},{"key":"146_CR13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1530\/eje.0.1490209","volume":"149","author":"S Giannini","year":"2003","unstructured":"Giannini S, Nobile M, Dalle Carbonare L, Lodetti MG, Sella S, Vittadello G et al (2003) Hypercalciuria is a common and important finding in postmeopausal women with osteoporosis. Eur J Endocrinol 149:209\u2013213. doi: 10.1530\/eje.0.1490209","journal-title":"Eur J Endocrinol"},{"key":"146_CR14","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1210\/jc.2002-020275","volume":"87","author":"C Tannebaum","year":"2002","unstructured":"Tannebaum C, Clark J, Schwartzman K, Wallenstein S, Lapinski R, Meier D et al (2002) Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab 87:4431\u20134437. doi: 10.1210\/jc.2002-020275","journal-title":"J Clin Endocrinol Metab"},{"key":"146_CR15","first-page":"90","volume":"48","author":"A Feitag","year":"2002","unstructured":"Feitag A, Barzel US (2002) Differential diagnosis of osteoporosis. Gerontology 48:90\u2013102","journal-title":"Gerontology"},{"key":"146_CR16","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1046\/j.1365-2796.2002.01040.x","volume":"252","author":"HA Deutschmann","year":"2002","unstructured":"Deutschmann HA, Weger M, Weger W, Kotanko P (2002) Search for occult secondary osteoporosis: impact of identified possible risk factors on bone mineral density. J Intern Med 252:389\u2013397. doi: 10.1046\/j.1365-2796.2002.01040.x","journal-title":"J Intern Med"},{"key":"146_CR17","doi-asserted-by":"crossref","first-page":"436","DOI":"10.4158\/EP.12.4.436","volume":"12","author":"SE Painter","year":"2006","unstructured":"Painter SE, Kleerekoper M, Camacho PM (2006) Secondary osteoporosis: a review of the recent evidence. Endocr Pract 12:436\u2013445","journal-title":"Endocr Pract"},{"key":"146_CR18","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1210\/jc.2005-0784","volume":"90","author":"MJ Favus","year":"2005","unstructured":"Favus MJ (2005) Postmenopausal osteoporosis and the detection of so-called secondary causes of low bone density. J Clin Endocrinol Metab 90:3800\u20133801. doi: 10.1210\/jc.2005-0784","journal-title":"J Clin Endocrinol Metab"},{"key":"146_CR19","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJM197503062921002","volume":"292","author":"CYC Pak","year":"1975","unstructured":"Pak CYC, Kaplan R, Bone H, Townsend J, Waters O (1975) A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias. N Engl J Med 292:497\u2013500","journal-title":"N Engl J Med"},{"key":"146_CR20","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1210\/jcem-47-4-751","volume":"47","author":"AE Broadus","year":"1978","unstructured":"Broadus AE, Dominguez D, Bartter FC (1978) Pathophysiological studies in idiopathic hypercalciuria: use of an oral calcium tolerance test to characterize distinctive hypercalciuric subgroups. J Clin Endocrinol Metab 47:751\u2013760","journal-title":"J Clin Endocrinol Metab"},{"key":"146_CR21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jbmr.5650030303","volume":"3","author":"JA Harvey","year":"1988","unstructured":"Harvey JA, Zobitz MM, Pak CYC (1988) Dose dependency of calcium absorption: a comparison of calcium carbonate and calcium citrate. J Bone Miner Res 3:253\u2013258","journal-title":"J Bone Miner Res"},{"key":"146_CR22","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","volume":"357","author":"MF Holick","year":"2007","unstructured":"Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266\u2013281","journal-title":"N Engl J Med"},{"key":"146_CR23","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/ajcn\/47.5.884","volume":"47","author":"SA Schuetter","year":"1988","unstructured":"Schuetter SA, Knowles JB (1988) Intestinal absorption of Ca(H2PO4)2 and Ca citrate compared by two methods. Am J Clin Nutr 47:884\u2013888","journal-title":"Am J Clin Nutr"},{"key":"146_CR24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1172\/JCI107774","volume":"54","author":"CYC Pak","year":"1974","unstructured":"Pak CYC, Ohata M, Lawrence EC, Snyder W (1974) The hypercalciurias: causes, parathyroid functions and diagnostic criteria. J Clin Invest 54:387\u2013400. doi: 10.1172\/JCI107774","journal-title":"J Clin Invest"},{"key":"146_CR25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s002239900618","volume":"64","author":"ST Haden","year":"1999","unstructured":"Haden ST, Fuleihan GEH, Angell JE, Cotran NM, LeBoff MS (1999) Calcidiol and PTH levels in women attending an osteoporosis program. Calcif Tissue Int 64:275\u2013279. doi: 10.1007\/s002239900618","journal-title":"Calcif Tissue Int"},{"key":"146_CR26","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1210\/jc.2004-2364","volume":"90","author":"MF Holick","year":"2005","unstructured":"Holick MF, Siris ES, Binkley N, Beard MK, Khan A, Katzer JT et al (2005) Prevalence of vitamin D insufficiency among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 90:3215\u20133224. doi: 10.1210\/jc.2004-2364","journal-title":"J Clin Endocrinol Metab"},{"key":"146_CR27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0002-9343(80)90495-7","volume":"69","author":"CYC Pak","year":"1980","unstructured":"Pak CYC, Britton F, Peterson R, Ward DL, Northcutt C, Breslau NA et al (1980) Ambulatory evaluation of nephrolithiasis: classification, clinical presentation and diagnostic criteria. Am J Med 69:19\u201330. doi: 10.1016\/0002-9343(80)90495-7","journal-title":"Am J Med"},{"key":"146_CR28","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1172\/JCI108696","volume":"59","author":"RA Kaplan","year":"1977","unstructured":"Kaplan RA, Haussler MR, Deftos LJ, Bone H, Pak CYC (1977) The role of 1\u03b1, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria. J Clin Invest 59:756\u2013760. doi: 10.1172\/JCI108696","journal-title":"J Clin Invest"},{"key":"146_CR29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1210\/jcem-58-1-161","volume":"58","author":"AE Broadus","year":"1984","unstructured":"Broadus AE, Erickson SB, Gertner JM, Cooper K, Dobbins JW (1984) An experimental human model of 1, 25-dihydroxy vitamin D-mediated hypercalciuria. J Clin Endocrinol Metab 58:161\u2013169","journal-title":"J Clin Endocrinol Metab"},{"key":"146_CR30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM198407123110201","volume":"311","author":"AE Broadus","year":"1984","unstructured":"Broadus AE, Insogna KL, Lang R, Ellison AF, Dreyer BE (1984) Evidence of disordered control of 1, 25-dihydroxyvitamin D production in absorptive hypercalciuria. N Engl J Med 311:73\u201380","journal-title":"N Engl J Med"},{"key":"146_CR31","first-page":"1446","volume":"75","author":"NA Breslau","year":"1992","unstructured":"Breslau NA, Preminger GM, Adams BV, Otey J, Pak CYC (1992) Use of ketoconazole to probe the pathogenetic importance of 1, 25-dihydroxyvitamin D in absorptive hypercalciuria. J Clin Endocrinol Metab 75:1446\u20131452. doi: 10.1210\/jc.75.6.1446","journal-title":"J Clin Endocrinol Metab"},{"key":"146_CR32","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1359\/JBMR.041120","volume":"20","author":"AJ Karnauskas","year":"2005","unstructured":"Karnauskas AJ, van Leeuwen JP, van den Bemd GJ, Kathpalia PP, DeLuca HF, Bushinsky DA et al (2005) Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming rats. J Bone Miner Res 20:447\u2013454. doi: 10.1359\/JBMR.041120","journal-title":"J Bone Miner Res"},{"key":"146_CR33","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1210\/jcem.87.4.8300","volume":"87","author":"BY Reed","year":"2002","unstructured":"Reed BY, Gitomer WL, Heller HJ, Hsu MC, Lempke M, Padalino P et al (2002) Identification and characterization of a gene with base substitutions associated with absorptive hypercalciuria phenotype and low spinal bone density. J Clin Endocrinol Metab 87:1476\u20131485. doi: 10.1210\/jc.87.4.1476","journal-title":"J Clin Endocrinol Metab"},{"key":"146_CR34","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1210\/jc.2004-0952","volume":"90","author":"CV Odvina","year":"2005","unstructured":"Odvina CV, Zerwekh ZE, Rao DS, Maalouf N, Gottschalk F, Pak CYC (2005) Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 90:1291\u20131301","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Urological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00240-008-0146-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00240-008-0146-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00240-008-0146-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T13:53:57Z","timestamp":1558706037000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00240-008-0146-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,17]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["146"],"URL":"https:\/\/doi.org\/10.1007\/s00240-008-0146-4","relation":{},"ISSN":["0300-5623","1434-0879"],"issn-type":[{"value":"0300-5623","type":"print"},{"value":"1434-0879","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,17]]}}}